Press Release Description

USD 2.09 Billion Global Carrier Screening Market to Accelerate at a CAGR of around 20.7% During the Forecast Period

The Global Carrier Screening Market size was valued at about USD 2.09 billion in 2023 & is anticipated to grow at a CAGR of around 20.7% during the forecast period, i.e., 2024–30, cites MarkNtel Advisors in the recent research report. The Carrier Screening Industry provides genetic testing designed to identify individuals carrying genetic mutations that can lead to inherited diseases. These tests are frequently recommended to couples who are considering parenthood or are already expecting, to assess the risk of transmitting a genetic disorder to their offspring. The primary goal of this sector is to offer precise and complete information, enabling individuals to make knowledgeable choices about their reproductive health.

The introduction of advanced carrier screening panels marks a significant milestone. These panels can screen a wide array of genetic diseases, thereby positioning themselves as a cornerstone in today's healthcare practices. Their development is celebrated not merely for the broadening of the spectrum of diseases that can now be screened for but also for the substantial improvements they bring to the table in terms of carrier screening accuracy, efficiency, and speed, bringing about a transformative change in how genetic diseases are detected and managed.

Global Carrier Screening Market

Moreover, the notable expansion of this market is attributed to breakthroughs in genetic screening technology and the increased availability of comprehensive carrier screening panels. These innovations have transformed how healthcare providers address genetic conditions, shifting towards a more proactive and inclusive care approach. With ongoing technological progress integrating further into healthcare systems, the value and importance of advanced carrier screening panels are expected to rise, propelling market growth and enriching patient care, further states the research report, “Global Carrier Screening Market Analysis, 2024.”

Segmentation Analysis

Hematologic Conditions Holding the Largest Share of the Market

Based on the medical conditions segment, the market is further bifurcated into hematologic conditions, pulmonary conditions, neurological conditions, and others. Hematologic conditions have a major share of the market and are projected to encounter the most significant market development in the forthcoming period in the carrier screening industry. This development is credited to the heightening predominance of thalassemia around the world, a hereditary problem affecting the creation of hemoglobin and bringing about frailty.

Carrier screening is considered a pivotal part of distinguishing people holding onto changes connected to thalassemia, especially inside populations showing an uplifted predominance of these transformations. Besides, the frequency of specific hematologic problems within a population could fundamentally add to the interest in carrier screening focusing on this segment.

North America to Lead Carrier Screening Industry

North America is anticipated to lead the Global Carrier Screening Market during the projected timeframe. The healthcare industry thrives in this developed region, which boasts a highly sophisticated infrastructure that supports the industry's growth. Advanced laboratories, research facilities, and healthcare institutions play a big part in the swifter adoption of progressive diagnostic technologies such as carrier screening. The region is home to many renowned research facilities & educational centers, and many of these institutions lead global genetic research efforts, particularly in rare diseases. This in turn positively impacts the demand for carrier screening services.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including Natera, Inc., Quest Diagnostics Incorporated, Fulgent Genetics, Invitae Corporation, Eurofins Scientific, Opko Health, Inc., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Illumina, Inc., Centogene N.V., Diasorin S.P.A., Otogenetics, Genetech, Laboratory Corporation of America Holdings, and others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

  1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
  2. What are the trends influencing the current scenario of the market?
  3. What key factors would propel and impede the industry across the region?
  4. How has the industry been evolving in terms of geography and service adoption?
  5. How has the competition been shaping up across various nations?
  6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2019-30?
  7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?

Place an order
Only market data will be provided in the excel spreadsheet.

USD 3,700

The report will be delivered in PDF format without printing rights. It is advised for a single user.

USD 4,850

The report will be delivered in PDF format with printing rights. It is advised for up to five users.

USD 6,000

The report will be delivered in PDF format with printing rights and excel sheet. It is advised for companies where multiple users would like to access the report from multiple locations

USD 7,500

Need Assistance?

WRITE AN EMAIL

[email protected]
100% Safe & Secure

Strongest encryption on the website to make your purchase safe and secure